Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

被引:479
作者
Mandelblatt, Jeanne S. [1 ]
Cronin, Kathleen A.
Bailey, Stephanie
Berry, Donald A.
de Koning, Harry J.
Draisma, Gerrit
Huang, Hui
Lee, Sandra J.
Munsell, Mark
Plevritis, Sylvia K.
Ravdin, Peter
Schechter, Clyde B.
Sigal, Bronislava
Stoto, Michael A.
Stout, Natasha K.
van Ravesteyn, Nicolien T.
Venier, John
Zelen, Marvin
Feuer, Eric J.
机构
[1] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE;
D O I
10.7326/0003-4819-151-10-200911170-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.
引用
收藏
页码:738 / W247
页数:15
相关论文
共 50 条
[21]   Harms and benefits of mammographic screening for breast cancer in Brazil [J].
Migowski, Arn ;
Nadanovsky, Paulo ;
Vianna, Cid Manso de Mello .
PLOS ONE, 2024, 19 (01)
[22]   Collaborative Modeling of the Benefits and Harms Associated With Different US Breast Cancer Screening Strategies [J].
Mandelblatt, Jeanne S. ;
Stout, Natasha K. ;
Schechter, Clyde B. ;
van den Broek, Jeroen J. ;
Miglioretti, Diana L. ;
Krapcho, Martin ;
Trentham-Dietz, Amy ;
Munoz, Diego ;
Lee, Sandra J. ;
Berry, Donald A. ;
van Ravesteyn, Nicolien T. ;
Alagoz, Oguzhan ;
Kerlikowske, Karla ;
Tosteson, Anna N. A. ;
Near, Aimee M. ;
Hoeffken, Amanda ;
Chang, Yaojen ;
Heijnsdijk, Eveline A. ;
Chisholm, Gary ;
Huang, Xuelin ;
Huang, Hui ;
Ergun, Mehmet Ali ;
Gangnon, Ronald ;
Sprague, Brian L. ;
Plevritis, Sylvia ;
Feuer, Eric ;
de Koning, Harry J. ;
Cronin, Kathleen A. .
ANNALS OF INTERNAL MEDICINE, 2016, 164 (04) :215-+
[23]   The benefits and harms of breast cancer screening: an independent review [J].
Marmot, M. G. ;
Altman, D. G. ;
Cameron, D. A. ;
Dewar, J. A. ;
Thompson, S. G. ;
Wilcox, M. .
BRITISH JOURNAL OF CANCER, 2013, 108 (11) :2205-2240
[24]   Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses [J].
Braithwaite, Dejana ;
Walter, Louise C. ;
Izano, Monika ;
Kerlikowske, Karla .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 (05) :561-572
[25]   Health benefits and harms of mammography screening in older women (75+years)-a systematic review [J].
Mathieu, Erin ;
Noguchi, Naomi ;
Li, Tong ;
Barratt, Alexandra L. ;
Hersch, Jolyn K. ;
De Bock, Geertruida H. ;
Wylie, Elizabeth J. ;
Houssami, Nehmat .
BRITISH JOURNAL OF CANCER, 2023, 130 (2) :275-296
[26]   Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates [J].
Lew, Jie-Bin ;
Feletto, Elenora ;
Wade, Stephen ;
Caruana, Michael ;
Kang, Yoon-Jung ;
Nickson, Carolyn ;
Simms, Kate T. ;
Procopio, Pietro ;
Taylor, Natalie ;
Worthington, Oachim ;
Smith, David P. ;
Canfell, Karen .
PUBLIC HEALTH RESEARCH & PRACTICE, 2019, 29 (02)
[27]   Comparative Effectiveness of Alternative Prostate-Specific Antigen-Based Prostate Cancer Screening Strategies Model Estimates of Potential Benefits and Harms [J].
Gulati, Roman ;
Gore, John L. ;
Etzioni, Ruth .
ANNALS OF INTERNAL MEDICINE, 2013, 158 (03) :145-+
[28]   Harms of screening mammography for breast cancer in Japanese women [J].
Kasahara, Yoshio ;
Kawai, Masaaki ;
Tsuji, Ichiro ;
Tohno, Eriko ;
Yokoe, Takao ;
Irahara, Minoru ;
Tangoku, Akira ;
Ohuchi, Noriaki .
BREAST CANCER, 2013, 20 (04) :310-315
[29]   Screening Mammography Among Older Women: A Review of United States Guidelines and Potential Harms [J].
Mack, Deborah S. ;
Lapane, Kate L. .
JOURNAL OF WOMENS HEALTH, 2019, 28 (06) :820-826
[30]   Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening [J].
Mandrik, Olena ;
Zielonke, Nadine ;
Meheus, Filip ;
Severens, J. L. ;
Guha, Neela ;
Acosta, Rolando Herrero ;
Murillo, Raul .
INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (04) :994-1006